Seminal plasma enables selection and monitoring of active surveillance candidates using nuclear magnetic resonance-based metabolomics: A preliminary investigation

Background: Diagnosis and monitoring of localized prostate cancer requires discovery and validation of noninvasive biomarkers. Nuclear magnetic resonance (NMR)-based metabolomics of seminal plasma reportedly improves diagnostic accuracy, but requires validation in a high-risk clinical cohort. Materi...

Full description

Bibliographic Details
Main Authors: Matthew J. Roberts, Renee S. Richards, Clement W.K. Chow, Marion Buck, John Yaxley, Martin F. Lavin, Horst Joachim Schirra, Robert A. Gardiner
Format: Article
Language:English
Published: Elsevier 2017-12-01
Series:Prostate International
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2287888217300387